Starvation triggers Abeta42 generation from human umbilical vascular endothelial cells

FEBS Letters
Jian-Fang MaSheng-Di Chen

Abstract

Cerebral amyloid angiopathy is a common feature in Alzheimer's disease (AD), which is characterized by amyloid deposit around brain vessels including capillaries. The origin of the amyloid protein of CAA remains controversial. In our work, we provide data to show that primary umbilical vein endothelial cells (HUVEC) harbor APP processing secretases and can produce Abeta(42) under starvation. Starvation can increase the secretion of Abeta(42) by altering the expression of beta-secretases (BACE1) and gamma-secretases (APH and PEN2). This process is regulated by macroautophagy. Suppression of macroautophagy induction by 3MA further increased the level of Abeta(42) produced under starvation in HUVECs. These results suggest that starvation-induced Abeta(42) secretion might contribute to the formation of CAA and hence vascular degeneration in AD.

References

Apr 1, 1991·Neuron·D J Selkoe
Oct 30, 1998·The Journal of Laboratory and Clinical Medicine·T A DaviesE R Simons
May 20, 2000·Annals of the New York Academy of Sciences·R O WellerA E Roher
Sep 6, 2002·Journal of Alzheimer's Disease : JAD·Jorge Ghiso, Blas Frangione
Jul 2, 2003·Journal of Neuropathology and Experimental Neurology·Janusz FrackowiakBozena Mazur-Kolecka
Dec 5, 2003·Acta Neuropathologica·Johannes Attems, Kurt A Jellinger
Dec 25, 2003·Journal of Neuropathology and Experimental Neurology·Dietmar Rudolf ThalOtmar D Wiestler
Nov 6, 2004·Science·Takahiro Shintani, Daniel J Klionsky
Jun 2, 2005·Nature Reviews. Molecular Cell Biology·Eric H Baehrecke
Oct 6, 2005·The Journal of Cell Biology·W Haung YuRalph A Nixon
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rodney A VelliquetteRobert Vassar
Sep 16, 2006·Molecular Aspects of Medicine·Brinda Ravikumar, David C Rubinsztein
Feb 20, 2007·Neurobiology of Aging·Mireia ComaFrancisco J Muñoz
Apr 18, 2007·Autophagy·Jan D LünemannChristian Münz
May 1, 2007·Annals of Neurology·Jan D LünemannChristian Münz
Sep 6, 2007·Genes & Development·Chanhee KangLeon Avery
Jun 24, 2008·Molecular Cell·Yongjie WeiBeth Levine
Jul 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Barry BolandRalph A Nixon
Mar 10, 2009·Autophagy·Shih-Ya HungWen-Mei Fu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.